Macintosh Blade Size During Laryngoscopy for Endotracheal Intubation. A Prospective Observational Study. (MacSize)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France
- Recruiting
- CHU
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients must be admitted in an operative room, an intensive care unit (ICU) or an emergency department and require mechanical ventilation through an orotracheal tube.
- Adult (age ≥ 18 years)
- Subjects must be covered by public health insurance
- Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency.
Exclusion Criteria:
- Anticipated difficult intubation requiring videolaryngoscopy
- Nasotracheal intubation
- Refusal of study participation or to pursue the study by the patient
- Absence of coverage by the French statutory healthcare insurance system
- Protected person
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Macintosh blade size 3
Patients intubated using Macintosh blade size 3
|
Patients in operative room, intensive care unit and emergency department requiring direct laryngoscopy for endotracheal intubation
|
|
Macintosh blade size 4
Patients intubated using Macintosh blade size 4
|
Patients in operative room, intensive care unit and emergency department requiring direct laryngoscopy for endotracheal intubation
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with successful first-pass orotracheal intubation
Time Frame: At intubation
|
The proportion of patients with successful first-pass orotracheal intubation
|
At intubation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severe complications related to intubation_hypoxemia
Time Frame: At intubation
|
Rate of severe hypoxemia defined by lowest oxygen saturation (SpO2) < 80 %
|
At intubation
|
|
Severe complications related to intubation_severe collapse
Time Frame: At intubation
|
Rate of cardiovascular collapse, defined as systolic blood pressure less than 65 mm Hg recorded at least once or less than 90 mm Hg lasting 30 minutes despite 500-1,000 ml of fluid loading (crystalloids solutions) or requiring introduction or increasing doses by more than 30% of vasoactive support
|
At intubation
|
|
Severe complications related to intubation_cardiac arrest
Time Frame: At intubation
|
Rate of cardiac arrest
|
At intubation
|
|
Severe complications related to intubation_death
Time Frame: At intubation
|
Rate of death during intubation
|
At intubation
|
|
Moderate complications related to intubation_difficult intubation
Time Frame: At intubation
|
Rate of difficult intubation
|
At intubation
|
|
Moderate complications related to intubation_arrythmia
Time Frame: At intubation
|
Rate of severe ventricular or supraventricular arrhythmia requiring intervention
|
At intubation
|
|
Moderate complications related to intubation_oesophageal intubation
Time Frame: At intubation
|
Rate of oesophageal intubation
|
At intubation
|
|
Moderate complications related to intubation_agitation
Time Frame: At intubation
|
Rate of agitation
|
At intubation
|
|
Moderate complications related to intubation_aspiration
Time Frame: At intubation
|
Rate of pulmonary aspiration
|
At intubation
|
|
Moderate complications related to intubation_dental injuries
Time Frame: At intubation
|
Rate of dental injuries
|
At intubation
|
|
Cormack Lehane
Time Frame: During intubation
|
Rate of Cormack-Lehane grade of glottic view
|
During intubation
|
|
Difficulty of intubation
Time Frame: During intubation
|
Rate of operator-assessed difficulty of intubation
|
During intubation
|
|
Additional airway equipment
Time Frame: During intubation
|
Rate of need for additional airway equipment (video laryngoscope, bougie, stylet, fibroscope, cricothyrotomy)
|
During intubation
|
|
Additional second operator
Time Frame: During intubation
|
Rate of need for a second operator
|
During intubation
|
|
POGO (percentage of glottic opening)
Time Frame: During intubation
|
Rate of POGO grade of glottic view
|
During intubation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- IRB 00010254-2021-016
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.